PeptidesRx vs ReadyRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
PeptidesRx
Best for patients prioritizing regulatory compliance in the compounded spaceStarting at $169/mo
ReadyRx
Best for compounded GLP-1 buyers who want LegitScript certification and explicit batch lab testing claims at a sub-$200 starting priceStarting at $179/mo
Side-by-Side Comparison
| Feature | PeptidesRx | ReadyRx |
|---|---|---|
| Overall Score | ✓7.9/10 | 7.2/10 |
| Starting Price | ✓$169/mo | $179/mo |
| Editorial Rating | ✓4 ★ /5 | 3.6 ★ /5 |
| Features | ✓6 features | 5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
PeptidesRx
Pros
- ✓Compliance-focused positioning vs gray-market vendors
- ✓Board-certified medical director
- ✓Transparent pricing with no surprise fees
- ✓Real prescriptions, not research-chemical channel
Cons
- ✗Smaller scale than Henry Meds or Hims
- ✗Wide peptide menu may distract from GLP-1 focus
ReadyRx
Pros
- ✓LegitScript certified — directly verifiable via the badge link in the footer
- ✓Batch lab testing claim covers four standard QA categories (potency, sterility, pH, endotoxicity) — these are the right metrics for compounded injectables
- ✓Pricing publicly displayed: $179/mo semaglutide, $255/mo tirzepatide
Cons
- ✗Specific FDA-registered pharmacy partner names are not disclosed publicly — claim is generic ('FDA-registered compounding pharmacies')
- ✗Clinical staff are described as 'Licensed, board-certified clinicians' but no individual NPIs or names are published on the homepage
- ✗5,000+ member figure is sourced from a competitor directory, not independently audited
Our Verdict
PeptidesRx edges out ReadyRx with a higher overall score of 7.9/10 and is particularly strong for patients prioritizing regulatory compliance in the compounded space. ReadyRx remains a solid alternative, especially if you're looking for compounded GLP-1 buyers who want LegitScript certification and explicit batch lab testing claims at a sub-$200 starting price.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.